{"id":15667,"date":"2023-11-21T15:35:23","date_gmt":"2023-11-21T14:35:23","guid":{"rendered":"https:\/\/udic.es\/?p=15667"},"modified":"2023-11-21T15:35:23","modified_gmt":"2023-11-21T14:35:23","slug":"an-option-to-modify-the-progressive-course-of-parkinsons","status":"publish","type":"post","link":"https:\/\/udic.es\/en\/an-option-to-modify-the-progressive-course-of-parkinsons\/","title":{"rendered":"An option to modify the progressive course of Parkinson’s"},"content":{"rendered":"
We evaluated an inhibitor of the LRRK 2 gene in patients with Parkinson’s. Oral treatment.
\nWe continue the development of new treatments that aim to modify the natural history of the disease, slowing its progression.<\/p>\n","protected":false},"excerpt":{"rendered":"
We evaluated an inhibitor of the LRRK 2 gene in patients with Parkinson’s. Oral treatment. We continue the development of new treatments that aim to modify the natural history of the disease, slowing its progression.<\/p>\n","protected":false},"author":5,"featured_media":9251,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-15667","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"yoast_head":"\n